申请人:National De La Sante et De La Recherche Medicale
公开号:US05290790A1
公开(公告)日:1994-03-01
The compounds correspond to the general formula ##STR1## in which R.sub.1 represents a hydrogen atom or a group --COR.sub.2, in which R.sub.2 represents a benzene ring, cyclopentylmethyl, cyclohexylmethyl, cyclopentylethyl or cyclohexylethyl groups or cyclopentylamine, cyclohexylamine or phenylamine, chlorophenylamine or dichlorophenylamine groups; R represents a hydrogen atom or a group COR.sub.3, in which R.sub.3 represents an aliphatic group, a cyclane or benzene ring-system, a group a group (CH.sub.2).sup.m R.sub.4, a group --CH.dbd.CHR.sub.8 or a secondary amine group --NH(CH.sub.2).sub.n R.sub.g ; R also represents a hydroxyalkenyl group: ##STR2##
这些化合物对应于一般公式##STR1##,其中R.sub.1代表氢原子或基团--COR.sub.2,其中R.sub.2代表苯环、环戊甲基、环己甲基、环戊基乙基或环己基乙基基团或环戊胺、环己胺或苯胺、氯苯胺或二氯苯胺基团;R代表氢原子或基团COR.sub.3,其中R.sub.3代表脂肪基、环己烷或苯环系统、基团(CH.sub.2).sup.m R.sub.4、基团--CH.dbd.CHR.sub.8或二级胺基团--NH(CH.sub.2).sub.n R.sub.g;R还表示羟基烯基基团:##STR2##